Shingles (Herpes Zoster) Vaccine News This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Pat yourself on the back, America. Your cholesterol levels are holding steady, CDC says.
When it comes to our health as a nation, we’re not doing so great. Some cancer rates are climbing sharply. Nearly one in eight Americans has diabetes. And we are ballooning in weight, with obesity rates at record highs. Amid that grim picture, government researchers on Thursday had a glimmer of good news: Our cholesterol numbers, […]Related:Rise in mumps outbreaks prompts U.S. panel to endorse 3rd vaccine doseExpert panel recommends new shingles vaccine that gives increased protectionFDA’s Gottlieb calls for greater use of medication-assisted treatment to fight opioid epidemic (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - October 26, 2017 Category: Consumer Health News Source Type: news

CDC Advisers Recommend New Herpes Zoster Vaccine over Zostavax (FREE)
By Kelly Young Edited by Susan Sadoughi, MD, and Richard Saitz, MD, MPH, FACP, DFASAM The CDC ' s Advisory Committee on Immunization Practices voted on Wednesday to recommend use of the newly approved herpes zoster vaccine, Shingrix.The inactivated, recombinant subunit, two-dosevaccine … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - October 26, 2017 Category: Primary Care Source Type: news

CDC Advisers Recommend New Herpes Zoster Vaccine over Zostavax (FREE)
By Kelly Young Edited by Susan Sadoughi, MD, and Richard Saitz, MD, MPH, FACP, DFASAM The CDC ' s Advisory Committee on Immunization Practices voted on Wednesday to recommend use of the newly approved herpes zoster vaccine, Shingrix.The non-live, recombinant subunit, two-dosevaccine … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - October 26, 2017 Category: Primary Care Source Type: news

ACIP Narrowly Recommends Shingrix for Shingles Over Zostavax ACIP Narrowly Recommends Shingrix for Shingles Over Zostavax
As a whole, the CDC panel is sold on the new recombinant vaccine to prevent herpes zoster, but some members want more safety data before they endorse it over Zostavax.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 25, 2017 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news

Rise in mumps outbreaks prompts U.S. panel to endorse 3rd vaccine dose
A federal expert panel on Wednesday recommended a third dose of the mumps vaccine when an outbreak occurs. The move was in response to the rise in mumps outbreaks since 2006, especially among highly vaccinated college students. More than 6,000 cases of the contagious viral illness were reported last year in the United States, the most […]Related:Expert panel recommends new shingles vaccine that gives increased protectionFDA’s Gottlieb calls for greater use of medication-assisted treatment to fight opioid epidemicWorld leaders rehearse for a pandemic that will come ‘sooner than we expect’ (Source: W...
Source: Washington Post: To Your Health - October 25, 2017 Category: Consumer Health News Source Type: news

CDC recommends new shingles vaccine to replace older one
A new adult vaccine has received a double thumbs-up from the American federal health system. (Source: CNN.com - Health)
Source: CNN.com - Health - October 25, 2017 Category: Consumer Health News Source Type: news

C.D.C. Panel Recommends a New Shingles Vaccine
Shingrix is considered much more effective than the older vaccine, Zostavax. Health officials urged consumers over age 50 to be vaccinated. (Source: NYT Health)
Source: NYT Health - October 25, 2017 Category: Consumer Health News Authors: SHEILA KAPLAN Tags: Shingles (Disease) Vaccination and Immunization Advisory Committee on Immunization Practices Centers for Disease Control and Prevention Source Type: news

Expert panel recommends new shingles vaccine that gives increased protection
A federal expert panel Wednesday recommended a new and more effective shingles vaccine to protect adults 50 and older from a painful rash that affects 1 in 3 people during their lifetime. In a rare move, the Advisory Committee on Immunization Practices also recommended, by an 8-to-7 vote, that the new Shingrix vaccine be preferred over […]Related:FDA’s Gottlieb calls for greater use of medication-assisted treatment to fight opioid epidemicWorld leaders rehearse for a pandemic that will come ‘sooner than we expect’U.S. abortion rate fell 25 percent from 2008 to 2014; one in four women have an aborti...
Source: Washington Post: To Your Health - October 25, 2017 Category: Consumer Health News Source Type: news

Panel recommends new, better shingles shot over old version
Federal panel recommends anyone vaccinated for shingles get a new, better shot approved last week (Source: ABC News: Health)
Source: ABC News: Health - October 25, 2017 Category: Consumer Health News Tags: Health Source Type: news

U.S. committee recommends GSK shingles vaccine over Merck rival
LONDON (Reuters) - The committee responsible for U.S. vaccination schedules has given a preferential recommendation to GlaxoSmithKline's newly approved shingles vaccine Shingrix over Merck& Co's established product Zostavax. (Source: Reuters: Health)
Source: Reuters: Health - October 25, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Correction: FDA-Shingles Vaccine story
(Source: ABC News: Health)
Source: ABC News: Health - October 25, 2017 Category: Consumer Health News Tags: Health Source Type: news

New Shingles Vaccine Approved by FDA
Title: New Shingles Vaccine Approved by FDACategory: Health NewsCreated: 10/23/2017 12:00:00 AMLast Editorial Review: 10/24/2017 12:00:00 AM (Source: MedicineNet Skin General)
Source: MedicineNet Skin General - October 24, 2017 Category: Dermatology Source Type: news

New Shingles Vaccine, Shingrix, Approved by FDA
A new, more effective shingles vaccine has been approved by the U.S. Food and Drug Administration. The new vaccine from GlaxoSmithKline will be the second shingles vaccine available in the U.S. market. The other is from Merck and was introduced in... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 23, 2017 Category: General Medicine Source Type: news

FDA approves better vaccine against shingles
Studies funded by the vaccine maker found it prevents painful shingles outbreaks in about 90 percent of people (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - October 23, 2017 Category: Consumer Health News Source Type: news

FDA Clears Shingles Vaccine Shingrix for Adults 50 and Older FDA Clears Shingles Vaccine Shingrix for Adults 50 and Older
The approval follows a unanimous vote last month by an FDA panel that concluded that the vaccine is effective and safe for adults aged 50 years and older.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 23, 2017 Category: Consumer Health News Tags: Infectious Diseases News Alert Source Type: news